ArticleActa pharmaceutica Sinica. B2024

Erratum: Author correction to 'VEGFR2-targeted antibody fused with IFNamut regulates the tumor microenvironment of colorectal cancer and exhibits potent anti-tumor and anti-metastasis activity' [Acta Pharm Sin B 11 (2021) 420-433].

Pengzhao Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.